Press Releases

Date

Title

View

27 Sep 18

Expedeon AG signs supply agreement with Reszon Diagnostics for proprietary colloidal gold technology (news with additional features)

View View

18 Sep 18

Expedeon AG comments on recent share price development (news with additional features)

View View

11 Sep 18

Expedeon AG announces commercial-use licence of proprietary technology in diagnostic assay (news with additional features)

View View

30 Aug 18

Expedeon AG secures GBP 5 million in debt financing (news with additional features)

View View

29 Aug 18

Expedeon AG to present at upcoming investor conferences (news with additional features)

View View

09 Aug 18

Expedeon AG (formerly SYGNIS AG) reports financial results for the first six months of 2018 and successful execution of name change (news with additional features)

View View

06 Jul 18

SYGNIS AG: SYGNIS AG announces outcome of Annual General Meeting 2018 (news with additional features)

View View

30 May 18

SYGNIS AG: SYGNIS AG proposes at AGM change of name to Expedeon AG (news with additional features)

View View

11 May 18

SYGNIS AG: SYGNIS AG reports strong financial results for first quarter of 2018 (news with additional features)

View View

09 May 18

SYGNIS AG: SYGNIS introduces 2view unique Western blot detection technology (news with additional features)

View View

08 May 18

SYGNIS AG: SYGNIS completes acquisition of TGR Biosciences (news with additional features)

View View

25 Apr 18

SYGNIS AG: SYGNIS AG reports financial results for fiscal year 2017 – financial guidance achieved (news with additional features)

View View